1.646.889.1200|info@lifescipublicrelations.com

Krystal moves towards ‘full integration’ with gene therapy facility opening

//Krystal moves towards ‘full integration’ with gene therapy facility opening

Krystal moves towards ‘full integration’ with gene therapy facility opening

Krystal opens cGMP facility for the clinical and commercial manufacture of its lead drug candidate, KB103, and plans to open its second in 2020.

By | 2019-03-08T16:15:04-04:00 March 7th, 2019|News|Comments Off on Krystal moves towards ‘full integration’ with gene therapy facility opening

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.